Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies by Yaqub, M.M. et al.
Optimization of supervised cluster analysis
for extracting reference tissue input curves
in (R)-[11C]PK11195 brain PET studies
Maqsood Yaqub1, Bart NM van Berckel1, Alie Schuitemaker2, Rainer Hinz3,
Federico E Turkheimer4, Giampaolo Tomasi5, Adriaan A Lammertsma1
and Ronald Boellaard1
1Department of Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam,
The Netherlands; 2Department of Neurology and Alzheimer Center, VU University Medical Center,
Amsterdam, The Netherlands; 3Wolfson Molecular Imaging Centre, University of Manchester, Manchester,
UK; 4Division of Experimental Medicine, Imperial College London, London, UK; 5Department of
Diagnostic Radiology, Yale University, New Haven, Connecticut, USA
Performance of two supervised cluster analysis (SVCA) algorithms for extracting reference tissue
curves was evaluated to improve quantification of dynamic (R)-[11C]PK11195 brain positron
emission tomography (PET) studies. Reference tissues were extracted from images using both a
manually defined cerebellum and SVCA algorithms based on either four (SVCA4) or six (SVCA6)
kinetic classes. Data from controls, mild cognitive impairment patients, and patients with
Alzheimer’s disease were analyzed using various kinetic models including plasma input, the
simplified reference tissue model (RPM) and RPM with vascular correction (RPMVb). In all subject
groups, SVCA-based reference tissue curves showed lower blood volume fractions (Vb) and volume
of distributions than those based on cerebellum time-activity curve. Probably resulting from the
presence of specific signal from the vessel walls that contains in normal condition a significant
concentration of the 18 kDa translocation protein. Best contrast between subject groups was seen
using SVCA4-based reference tissues as the result of a lower number of kinetic classes and the prior
removal of extracerebral tissues. In addition, incorporation of Vb in RPM improved both parametric
images and binding potential contrast between groups. Incorporation of Vb within RPM, together
with SVCA4, appears to be the method of choice for analyzing cerebral (R)-[11C]PK11195
neurodegeneration studies.
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Introduction
(R)-[11C]PK11195 is a widely used positron emis-
sion tomography (PET) ligand for the imaging of
activated microglia in the brain and provides means
to study neuroinflammation in brain disorders such
as Alzheimer’s disease (AD), schizophrenia, neuro-
trauma, and normal aging among others (Cagnin
et al, 2001; Gerhard et al, 2003; van Berckel et al,
2008; Schuitemaker et al, 2010). Quantification of
(R)-[11C]PK11195 uptake is also important for moni-
toring the effects of antiinflammatory therapy (Dodel
et al, 2010).
The gold standard for analysis of dynamic
(R)-[11C]PK11195 studies is the two tissue reversible
plasma input model (2T4k) (Gunn et al, 2001). The
2T4k model requires accurate arterial blood sam-
pling during the scan, which is invasive, complicates
logistics, and is prone to errors. Reference tissue
models, in contrast, do not require arterial blood
sampling and are therefore better suited for routine
clinical studies. However, a reference tissue model
needs to be validated before routine clinical use.
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In a previous study, Kropholler et al (2005)
evaluated both the plasma input model (2T4k) and
the simplified reference tissue model (SRTM; Lam-
mertsma and Hume, 1996) for analysis of dynamic
(R)-[11C]PK11195 studies. The binding potentials
(BPND) estimated using both models showed good
correlation. Nevertheless, SRTM-derived BPND can
be biased due to (specific) binding in the reference
region; for example, the cerebellum, a typical
reference region of choice, is surrounded by venous
sinuses that have significant concentration of TSPO
in endothelial tissue and smooth muscle (Turkhei-
mer et al, 2007). Besides, the pattern of microglial
activation is generally unknown and the choice of an
anatomical region as reference may be challenging
without appropriate pathological information.
Therefore, automatic approaches to extract reference
tissue kinetics of (R)-[11C]PK11195 would be appeal-
ing as long as sensitive and robust.
Turkheimer et al (2007) applied a new clustering
method for extracting reference tissue curves, called
supervised cluster analysis (SVCA6). The supervised
clustering algorithm segments PET voxels based on
differences in time-activity curves (TACs). The
method assumes that each TAC is a linear sum of
six predefined kinetic classes associated with gray
matter with specific binding, gray matter without
specific binding, white matter, blood, bone, and soft
tissue regions. This algorithm selects reference tissue
voxels primarily from gray-matter tissue without
specific binding avoiding binding in blood vessels.
It was shown that the use of SVCA6 extracted
reference tissues curves improved the agreement
between reference tissue and plasma input models
(Turkheimer et al, 2007).
Boellaard et al (2008) modified SVCA6 by remov-
ing bone and soft tissue regions from the PET scan
before SVCA analysis. The modified method
(SVCA4) only requires four kinetic classes; however,
it also requires a brain mask which usually can be
obtained from a magnetic resonance image (MRI) of
the subject. This improved precision, because of the
reduction in fit parameters and the elimination of
noise and errors from extracerebral signal coming
from bone and soft tissue regions. The SVCA4
provided more accurate reference tissues than cere-
bellum and SVCA6. However, it has also been
recently shown that variations in vascular binding,
typical for example of aging and neurodegenerative
disorders, may contribute significantly to the estima-
tion of BPND. Tomasi et al (2008) proposed a modified
SRTM method that corrects for vascular signal in the
target region based on an image-derived blood TAC.
This method uses a basis function implementation
of SRTM (i.e., RPM; Gunn et al, 1997) with blood
volume fraction (Vb) correction (RPMVb). They
reported that the use of RPMVb together with SVCA6
resulted in better differentiation of AD from controls.
Additionally, a group difference in estimated Vb
between healthy controls and AD patients was
found, which is in line with known pathological
changes in AD. The purpose of the present study was
to compare different methods for extracting reference
tissue for kinetic analysis of (R)-[11C]PK11195 stu-
dies. To this end, two assessments were performed:
(1) The extracted reference tissue curves were ana-
lyzed using the plasma input model with addi-
tional parameter for blood volume fraction (2T4k)
for the assessment of volume of distribution (VT)
and blood volume fraction (Vb).
(2) The extracted reference tissue curves were used
as input in various reference tissue algorithms
for the assessment of the specific binding (BPND)
in the target region ( = thalamus).
The second aim was to replicate the result of
Tomasi et al (2008), in a new cohort of AD patients as
further validation of the RPMVb modeling approach.
Reference TACs were extracted using SVCA4,
SVCA6, and manual definition of cerebellum.
Kinetic analysis of the target region was performed
using 2T4k, SRTM, RPM, and RPMVb. In all assess-
ments, data were used from young controls (YC), old
controls (OC), patients with mild cognitive impair-
ment (MCI), and patients with AD.
Materials and methods
Scanning Protocol
Clinical data were derived from patient studies, approved
by the Medical Ethics Review Committee of VU University
Medical Center, and consisted of 34 subjects (9 YC, 8 OC, 9
MCI, and 8 AD). The age range was 19 to 56 (average
27±11), 64 to 78 (average 72±5), 64 to 79 (average 72±6),
and 61 to 81 (average 72±6) for YC, OC, MCI, and AD,
respectively. Each subject gave written informed consent
before inclusion in the study.
After bolus injection of 370MBq (R)-[11C]PK11195, a
dynamic emission scan was acquired in 3D mode using an
ECAT EXACT HR+ (CTI/Siemens, Knoxville, TN, USA). In
addition, a 10-minute 2D transmission scan was acquired
to correct for tissue attenuation. The dynamic emission
scan consisted of 22 frames with a total scan duration of
60.5minutes (1 30, 1 15, 1 5, 1 10, 2 15, 2 30,
3 60, 4 150, 5 300, and 2 600 seconds). The first
frame has a relatively large duration because it is used as a
background frame to verify running of the scanner and
blood sampling device. Next, the tracer is injected during
the first 10 seconds of the second frame. The later frames
have shorter frame durations to be able to accurately obtain
the shape of the TACs during the initial uptake phase.
Frames were reconstructed using FORE (Defrise et al, 1997)
+ 2D Filtered Back Projection with a Hanning filter at a
cutoff of 0.5 times the Nyquist frequency. A matrix size
of 256 256 and a zoom factor of two were applied during
reconstruction, resulting in an image pixel size of
1.2 1.2mm and a slice thickness of 2.5mm. The recon-
struction settings resulted in an image resolution of 7mm
full width at half maximum. Reconstructions included
all usual corrections, such as detector normalization, and
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decay, dead time, attenuation, randoms, and scatter
corrections.
The arterial input function was measured using an
online continuous blood sampling device (Boellaard et al,
2001). At discrete times (B3, 6, 10, 20, 30, 40, and
60minutes after injection), additional manual samples
were obtained for online calibration of the measured whole
blood input function, determination of plasma/whole
blood ratios, and measurement of metabolite fractions.
The protocol included a T1-weighted MRI scan (1T
IMPACT, Siemens Medical Solutions, Erlangen, Germany)
to facilitate the definition of anatomical regions of interest
(ROIs).
Regions of Interest Definitions
First, the T1-weighted MRI scan was coregistered (West
et al, 1997; Maes et al, 1997) with the dynamic
(R)-[11C]PK11195 scan summed over 1 to 8minutes, where
the latter summed image approximates a flow image with
a fair contrast between gray and white matter. Next, the
coregistered T1-weighted MRI was segmented into gray
matter, white matter, and cerebrospinal fluid (Zhang et al,
2001). Next, anatomical ROIs for thalamus and cerebellum
were drawn manually on the coregistered T1-weighted
MRI. Finally, these ROIs were projected onto reconstructed
dynamic (R)-[11C]PK11195 images to extract regional TACs.
The thalamus was selected as target region because it is
known to have a relatively high level of specific binding
of (R)-[11C]PK11195 in AD (Schuitemaker et al, 2007). The
cerebellum ROI consisted of both gray and white matter
(Schuitemaker et al, 2007) and was used to extract a
reference tissue TAC for comparison with reference tissue
TACs extracted with the supervised cluster algorithms.
Supervised Cluster Analysis
Two SVCA algorithms were used to automatically extract
reference tissue TACs from dynamic PET scans. Predefined
kinetic classes were available from a previous study using
data from seven healthy controls and seven patients with
traumatic brain injury (Boellaard et al, 2008). Details
concerning this procedure and cluster analysis were
reported in Turkheimer et al (2007); however, a summary
of cluster analysis is as follows.
The original method (SVCA6) uses six kinetic classes
normal gray matter, normal white matter, blood, bone, and
soft tissue regions, and gray matter with specific binding.
The first five classes were defined on a separate set of
normal controls while the last one, corresponding to gray
matter with high microglia density, was obtained from the
brain injury patients.
To extract the reference, the dynamic PET scan is first
normalized as described by Turkheimer et al (2007): each
voxel value is reduced by the frame average and divided
by the standard deviation. Therefore, the normalization is
affected by the size of the reconstructed field of view; for
this study, both definition of kinetic classes and applica-
tion cluster analysis were preformed on scans acquired
from the same scanner using similar scanning protocol.
However, in case of using SVCA4, normalization was done
on voxels that correspond with brain tissue only (based on
MRI-derived coregistered gray- and white-matter segmen-
tations). Thereby, this method also avoids the effects of
differences in field of view between different scanners.
Next, each voxel TAC of this scan is analyzed using the
set of predefined kinetic classes to find the scaling
coefficient of each kinetic class, so that the total TAC is
equal to the sum of these scaled kinetic classes. As the
kinetic classes are not orthogonal, a nonnegative least
squares algorithm (Turkheimer et al, 2007) is used for
finding the scaling coefficients. Scaling coefficients of each
kinetic class are stored in coefficient maps showing their
spatial distribution.
Finally, to extract the reference tissue curve, the
coefficient map from the (normal) gray-matter kinetic class
is used to calculate the weighted average, as follows:
TACNSðtÞ ¼
PN
i¼1
w
Gray
i TACVoxeli ðtÞ
PN
i¼1
w
Gray
i
0
BBB@
1
CCCA ð1Þ
where, N is the number of voxels, TACNS(t) the resulting
reference tissue TAC, TACi
Voxel(t) the TAC from voxel i of
the (nonnormalized) dynamic PET scan, and wi
Gray the gray-
matter kinetic class scaling coefficient estimated for voxel i.
The modified supervised cluster analysis method
(SVCA4) (Boellaard et al, 2008) is similar to SVCA6,
except that only four kinetic classes are used: gray matter
with specific (R)-[11C]PK11195 binding, gray matter
without specific binding, white matter, and blood. This
modified method uses the mentioned coregistered segmented
MRI scans to exclude skull and soft tissue parts from each
frame of the PET scan before performing cluster analysis,
same as mentioned above but now with only four kinetic
classes. Removal of skull and soft tissue was simply done by
setting voxel values to zero for nonbrain structures.
Kinetic Analysis of Clinical Data
Each of extracted reference tissue TACs was analyzed using
a two tissue reversible plasma input model with additional
parameter for blood volume fraction (2T4k) (Gunn et al,
2001) for the assessment of volume of distribution (VT) and
blood volume fraction (Vb). As mentioned before, reference
tissue TACs were based on manual definition of cerebel-
lum or extracted using cluster analysis algorithms.
Next, extracted reference tissue curves were used as
input in four different reference tissue algorithms for the
assessment of the specific binding (BPND) in the target
region (e.g., thalamus). The reference tissue analysis was
performed using 2T4k, SRTM (Lammertsma and Hume
1996), the basis function approach of SRTM (RPM) (Gunn
et al, 1997), and the basis function approach of SRTM with
additional correction for blood volume fraction Vb (RPMVb)
(Tomasi et al, 2008). Note that in this step the 2T4k was
used to calculate the BPND indirectly, i.e., reference tissue
based, BPND was calculated using the thalamus to reference
tissue volume of distribution ratio DVR ( =VT_thalamus/
VT_reference_tissue=DVR=BPND+1).
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The SRTM, RPM, and RPMVb were mainly used to
calculate the BPND. The RPMVb requires an image-derived
blood curve to correct for Vb in the target TAC. The fractional
blood volume for the reference input TAC was fixed to 5% in
RPMVb that equals to the original implementation by Tomasi
et al (2008). The image-derived blood curve was defined as
the average TAC from 10 voxels showing the highest uptake
during the initial period (<1minutes) (Tomasi et al, 2008).
Optimization of image quality and quantification required
empirical assessment of the basis function parameters/range
in case of using RPM and RPMVb. The RPM was run using
number of basis functions of 30, ymin of 0.04/minute and ymax
of 1.0/minute (Gunn et al, 1997). The RPMVb was run using
number of basis functions of 30, ymin of 0.01/minute, and ymax
of 0.3/minute.
Both RPM and RPMVb methods are faster and more
robust against high noise levels than nonlinear methods
(i.e., SRTM and 2T4k); therefore, RPM and RPMVb were
used to calculate volumetric images showing the binding
potential for each image voxel ( = parametric BPND images).
Next, the manually defined ROI on segmented MRI
was projected onto parametric BPND images to calculate
regionally averaged BPND.
Results
Extraction of Reference Tissues
Kinetic classes used in SVCA6 and SVCA4 are
shown in Figure 1. The coefficient maps for each
kinetic class showed expected distributions (data
not shown): the blood pool was clearly visible and
healthy gray-matter maps (used for extraction of
reference tissue curve) are well identified. Coefficient
maps representing high specific binding showed high
uptake in the thalamus region and also uptake
(unexpectedly) in a region just outside the brain.
Figure 2 shows population average reference tissue
TACs for all eight AD subjects. In general, the highest
uptake was seen in the cerebellum TAC. The SVCA4
and SVCA6 TACs were slightly different in shape, and
SVCA6 showed overall higher uptakes than SVCA4.
Similar uptake differences between the reference
tissue curves were seen for the other clinical subject
groups (YC, OC, and MCI, not shown here).
Analysis of the Reference Tissue Curves Using Plasma
Input
Reference tissue Vb values obtained using plasma
input analysis (2T4k) are shown in Figure 3A. The
number of outliers shown in the figure (defined as
Figure 1 Typical time-activity curves (TACs) for the kinetic
classes used in SVCA6 (A) and SVCA4 (B). TACs were scaled by
subtracting from each time point the frame average and dividing
by the frame standard deviation. SVCA4 uses only four kinetic
classes and the curves are different because scaling is performed
after brain extraction. HSB stands for high specific binding (i.e.,
binding to activated microglia). SVCA, supervised cluster
analysis.
Figure 2 Average standardized reference tissue time-activity
curves (TACs) over all eight AD subjects. Curves represent
manually drawn gray+white-matter cerebellum (CER), and
those extracted automatically using SVCA4 and SVCA6. The
insert highlights the first 4minutes. TACs were normalized for
injected dose and patient weight before calculating averages
(symbols) and one standard deviation (error bars).
Reference tissue extraction for (R)-[11C]PK11195 studies
M Yaqub et al
1603
Journal of Cerebral Blood Flow & Metabolism (2012) 32, 1600–1608
interquartile range 1.5 outside first and third
quartiles) seems to be related to a clinical subject
group rather than to the reference tissue extraction
method, i.e., largest number of outliers was seen for
YC probably due to a lower specific signal in this
group. Note that all T-test analyses were performed
after removal of the shown outliers in the figures
using a significance level of P=0.05. Compared with
cerebellum, there are indications for lower Vb for
both the SVCA4- and SVCA6-derived reference
tissues (see two-tailed significance P in the figure).
However, the differences between the clinical subject
groups were similar for all methods, i.e., for all
methods group differences in Vb were only signifi-
cant between YC versus OC, YC versus MCI, and YC
versus AD (T-test data not shown).
Reference tissue VT values obtained using plasma
input analysis (2T4k) are shown in Figure 3B. Again,
the number of outliers shown in the figure seems to
be related to a clinical subject group rather than to
the reference tissue extraction method. There are
indications for lower VT for SVCA4-derived refer-
ence tissue compared with VT for cerebellum-based
reference tissue. Furthermore, only SVCA4 showed a
significantly different VT between YC versus MCI,
and YC versus AD, all other group comparisons for
each method were not significant (T-test data not
shown).
Estimation of Specific Binding in Thalamus Using
Plasma Input
VT values of the target region ( = thalamus) estimated
using plasma input analysis did not show any
significant differences among the groups (t-test data
not shown). Significant differences in VT between
target and reference tissue input were found for OC,
MCI, and AD, however, only in case of using SVCA4.
Figure 4 shows box plots of thalamus BPND
(derived from DVR-1) obtained using plasma input
analysis (2T4k) of both the reference input and
thalamus TAC, in this case, T-test significance levels
are given for comparison between groups for each
method. Overall, use of SVCA4 generated higher
specific binding in thalamus than the other reference
tissue extraction methods. Differences between cer-
ebellum input and SVCA4 were significant for most
clinical subject groups (data not shown). Also, the
largest variability was seen for SVCA4 values in MCI
and AD. Nevertheless, thalamus BPND estimates using
SVCA methods were in most cases significantly higher
for subjects with increasing pathology (Figure 4).
Figure 3 Comparison of reference tissue Vb (A) and VT (B) using
box and whisker plots, including two-tailed T-test analysis for
comparison between methods. Reference tissue time-activity
curves (TACs) were based on manually drawn gray+white-
matter cerebellum (CER), and those extracted automatically
using SVCA4 and SVCA6. Data were taken from young controls
(YC), old controls (OC), and patients with mild cognitive
impairment (MCI) and Alzheimer’s disease (AD). Note that all
two-tailed T-tests were performed after removing the outliers
(marked with open circles) shown in the figure.
Figure 4 Comparison of thalamus-specific binding potential
(BPND) using box and whisker plots, including two-tailed T-test
analysis for comparison between groups. BPND (=DVR-1)
was calculated using thalamus to reference tissue VT ratio’s.
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Estimation of Specific Binding in Thalamus without
Plasma Input
In Figure 5, several typical parametric BPND images
(RPM and RPMVb) are shown. In general, use of both
SVCA methods showed large contrast between gray-
and white-matter areas compared with the use of the
cerebellum as reference input. In addition, use of
RPMVb showed higher contrast in the brain tissues
and less (R)-[11C]PK11195 binding in extracerebral
tissues (in or near the skull) than when using RPM.
Regional thalamus BPND values obtained using
SRTM were almost identical to corresponding RPM
results (data not shown). Therefore, SRTM results are
not shown. Figure 6 shows box plots for thalamus
BPND estimated using either RPM or RPMVb in
combination with cerebellum, SVCA4, or SVCA6
reference tissue curves. Table 1 shows multiple two-
tailed t-test analyses performed on these data (after
removing outliers shown in the figure) to investigate
the differences between each method (Table 1) and
for each method the differences between clinical
subject groups (Table 1). Again, BPND based on
cerebellum reference tissue was not significantly
different between subject groups (Figure 6; Table 1),
whereas SVCA-based BPND showed more contrast
(Figure 6; Table 1). By comparing methods, it was
observed that there are larger differences between
cerebellum and SVCA4 input than between cerebel-
lum and SVCA6 methods (Table 1). Furthermore,
results are significantly changed when applying
Vb correction in SVCA methods. Finally, only use
of RPMVb with SVCA4-based reference tissue input
showed significant differences between all groups
(Table 1) except OC versus MCI.
Discussion
Reference Tissue
During the extraction of reference tissues the coeffi-
cient maps for each kinetic class showed expected
distributions (data not shown). However, coefficient
maps representing high specific binding also showed
some uptake (unexpectedly) in a region just outside
the brain. This does not affect the reference tissue
extraction process because the coefficient maps for
the (healthy) gray matter (that was used to extract the
Figure 5 Parametric binding potential (BPND) images generated using reference tissue model (RPM) (top row) and RPM with
vascular correction (RPMVb) (bottom row). Reference tissue inputs were taken from cerebellum (CER), SVCA4, and SVCA6. Note the
higher contrast when using RPMVb (bottom row). Data were taken from an AD subject.
Figure 6 Comparison of thalamus-specific binding (BPND) using
box and whisker plots.
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reference input curves) were well identified without
high probability values outside the brain.
Reference tissue TACs extracted from cerebellum
and the two cluster analysis algorithms did not show
similar uptake (Figure 2). Similar results were found
for different clinical subject groups. Reference tissue
curves extracted using SVCA4 always showed lower
uptake than the two other methods (Figure 2).
Increased uptake at the peak of the cerebellum TAC
hints toward contributions from the vascular compo-
nent; at first, the vascular contribution will reflect
radiotracer in blood and the increased uptake at the
latter part of the TAC is likely to reflect binding in
endothelium and smooth muscles (Figure 2).
The fractional blood volume of the reference tissue
curves was estimated using the 2T4k model with
correction for the blood volume fraction. In general,
for all reference tissue extraction methods, analysis
of the reference tissue curves showed a decreasing Vb
with increasing probability of pathology in the brain
(Figure 3A), the exact reason for this decrease is
unknown. In theory, both SVCA algorithms should
produce reference tissue TACs that are free of blood
(i.e., Vb=0), as they have a separate kinetic class for
blood. For both methods, however, reference tissue
Vb was only slightly lower than that for the manually
defined cerebellum TAC (Figure 3A). This indicates
that cluster analysis is only partly capable of
correcting for the intravascular contribution in the
reference tissue. There can be several reasons for this
observation. First, ROIs defined to obtain the gray-
matter kinetic class may also contain intravascular
activity and second, partial volume effects due to the
low resolution of PET images may compromise refer-
ence tissue TACs. Third, the SVCA used only one
kinetic class to describe the tracer kinetics in blood.
However, a significant arterial-venous gradient of the
activity concentration of (R)-[11C]PK11195 due to its
high extraction exists; therefore, the vasculature may
not be completely captured by that single blood class.
The volume of distribution, VT, was estimated
using the 2T4k model with correction for the blood
volume fraction. The VT should give an estimate of
uptake of the tracer in tissue. For all reference tissue
extraction methods, analysis of the reference tissue
curves themselves using the two tissue reversible
plasma input model showed a decreasing VT with
increasing probability of pathology in the brain
(Figure 3B). In all subject groups, SVCA4 showed
the lowest VT values. Furthermore, only SVCA4
showed a significantly different VT between YC
versus MCI, and YC versus AD. All other group
comparisons did not show significant differences in
VT. The lower VTwith SVCA4 resulted possibly from
less binding in the extracted reference tissue or
binding in blood vessel walls.
Specific Binding
VT values of the target region ( = thalamus) estimated
using plasma input analysis did not show any
significant differences among the groups. However,
VT is not only reflecting specific binding, but also
includes a large (and intersubject variable) contribu-
tion of nonspecific binding. Therefore, VT is not very
sensitive to pick up differences in specific binding.
Significant differences in VT between target and
Table 1 BPND estimates were compared using two-tailed t-test: (a) for each reference tissue method are given the significance levels
for testing differences in the clinical subject groups; (b) for each clinical subject group are given the significance levels for testing
differences in the reference tissue methods
Test RPM cerebellum RPM SVCA4 RPMVb SVCA4 RPM SVCA6 RPMVb SVCA6
(a)
YC versus OC 0.266 0.000 0.000 0.025 0.004
YC versus MCI 0.167 0.019 0.004 0.142 0.017
YC versus AD 0.137 0.000 0.000 0.007 0.005
OC versus MCI 0.779 0.690 0.452 0.519 0.581
OC versus AD 0.911 0.295 0.050 0.209 0.435
MCI versus AD 0.809 0.299 0.039 0.144 0.286
Test YC OC MCI AD
(b)
RPM CER versus RPM SVCA4 0.002 0.000 0.001 0.000
RPM CER versus RPMVb SVCA4 0.030 0.008 0.241 0.000
RPM CER versus RPM SVCA6 0.078 0.000 0.021 0.000
RPM CER versus RPMVb SVCA6 0.013 0.499 0.195 0.803
RPM SVCA4 versus RPMVb SVCA4 0.000 0.001 0.022 0.021
RPM SVCA4 versus RPM SVCA6 0.153 0.000 0.026 0.002
RPM SVCA6 versus RPMVb SVCA6 0.001 0.000 0.003 0.003
RPMVb SVCA4 versus RPMVb SVCA6 0.628 0.002 0.075 0.000
BPND, binding potential; CER, cerebellum; RPM, reference tissue model; RPMVb, RPM with vascular correction; SVCA, supervised cluster analysis.
Data were taken from young controls (YC), old controls (OC), and patients with mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Significant
P values are indicated with bold fonts.
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reference tissue input were found for OC, MCI, and
AD, however, only in case of using SVCA4. The latter
differences are as expected because the VT target to
VT reference tissue ratio (plasma input-based
DVR=BPND+1) is an estimate of specific binding
and therefore a more suitable parameter to evaluate
tracer binding.
The specific binding (BPND) was estimated using
reference tissue methods with or without plasma
input. The results of BPND using different reference
tissue TACs were analyzed for accuracy. Although
accuracy is difficult to estimate for clinical data
because the underlying true parameters are not
known, both box plots and (expected) differences
between subject groups can be used as an index of
performance. Therefore, here the focus was on
evaluating tracer binding in the thalamus because
this area was found to show differences in binding in
several other studies (Banati et al, 2000; Schuite-
maker et al, 2010).
Although the plasma input-based specific binding
is also corrected for the differences in Vb between the
target and the reference region, still similar outcomes
(Figure 4) were seen in the nonplasma input-based
reference tissue methods (Figure 6). In general, one
could conclude that SVCA4 showed higher binding
in all subject groups than all other methods (Figures
4 and 6). However, expected differences between
subject groups were only significant when using
SVCA method (Table 1). Furthermore, parametric
images based on SVCA reference tissue input
functions showed higher contrast and appeared less
noisy (Figure 5). Clearly, cerebellum-based reference
tissue input curves were less suitable than those of
SVCA when using a reference tissue model for
analyzing (R)-[11C]PK11195 data.
Finally, incorporation of Vb in the model improved
both gray- and white-matter contrast in parametric
images (Figure 5) and BPND contrast between groups
(Table 1). A possible explanation of this observation
could be that (R)-[11C]PK11195 binds specifically in
the blood vessel walls, which then needs to be
corrected for by the model (Tomasi et al, 2008). The
RPMVb algorithm effectively corrects for this effect in
both reference tissue and target region without the
need of arterial sampling.
Possible Limitations of Cluster Analysis
Cluster analysis requires a set of predefined kinetic
classes, which are generated from manually defined
ROIs on selected (R)-[11C]PK11195 scans (Turkhei-
mer et al, 2007; Boellaard et al, 2008; Hinz et al,
2008). Next, dynamic (R)-[11C]PK11195 PETscans are
analyzed using this set of predefined kinetic classes.
After normalization of the kinetic classes, only
relative shape differences between the kinetic classes
are important (Figure 1). The shape of the various
kinetic classes depends on both scanning protocol
(e.g., speed of bolus injection) and characteristics of
the PET scanner and image reconstruction (Boellaard
et al, 2008). As a consequence, kinetic classes may
have to be derived at, or validated for, each site, at
least per type of PET scanner or when using different
imaging procedures. This may limit the use of SVCA.
However, recently another study applied a similar
approach with predefined kinetic classes to enhance
the visualization of tumors imaged with [18F]FLT
(Gray et al, 2010) showing the feasibility of using
comparable supervised cluster methods for other
applications. Yet, further research is needed to
explore the applicability of these approaches to other
tracers and scanners.
In our study, the used kinetic classes were
redefined for our setting (scanner and imaging
procedure) during a previous study (Boellaard et al,
2008), using dynamic (R)-[11C]PK11195 brain PET
studies from seven young healthy controls and seven
patients with traumatic brain injury. The latter
studies were only used to obtain the kinetic class
representing high specific binding.
The SVCA4 needs additional preprocessed PET
data for which the skull and soft tissues outside
the brain are automatically removed using a coregis-
tered T1-weighted MRI scan. Use of smaller number
of kinetic classes (SVCA4 versus SVCA6) could
result in reduced sensitivity for noise because the
clustering algorithm requires fewer fit parameters
(Boellaard et al, 2008). However, accurate coregistra-
tion and gray–white matter versus cerebrospinal
fluid segmentation are required to correctly remove
nonbrain tissues from the PET study. Small mis-
alignments could result in incorrect removal of brain
tissue or residual nonbrain voxels in the processed
PET images. Therefore, in our study all preprocessed
PET data were first inspected visually.
Conclusion
The SVCA4 provided reference tissue input curves
with lower volumes of distribution and blood
volume fractions than those obtained using a cere-
bellum ROI or SVCA6. Moreover, the use of cere-
bellum as reference region was not able to show
differences in specific binding between subject
groups, while use of SVCA (4 or 6) did show group
differences in specific binding. Based on the ability
to show differences in binding between subject
groups as well as showing lowest reference VT and
Vb, SVCA4 in combination with RPMVb might
be the method of choice for analyzing dynamic
(R)-[11C]PK11195 brain PET studies.
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